Improving palbociclib adherence among women with metastatic breast cancer using a CONnected CUstomized Treatment Platform: A pilot study.

Gelareh SadighJane L MeiselKristina ByersAndrew RoblesLeslie SerranoOlivia S JungDebrua ColemanKatherine A YeagerIlana Graetz

Published in: Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners (2023)

The CONnected CUstomized Treatment Platform interventions is feasible, resulting in a high palbociclib adherence rate without any decline in overtime. Future efforts should focus on improving usability.

Keyphrases

metastatic breast cancer
high throughput
healthcare
physical activity
type diabetes
adipose tissue
current status
quality improvement
insulin resistance
social media
single cell